tiprankstipranks
Trending News
More News >
Vor Biopharma (VOR)
NASDAQ:VOR
US Market

Vor Biopharma (VOR) Income Statement

Compare
952 Followers

Vor Biopharma Income Statement

Last quarter (Q3 2025), Vor Biopharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Vor Biopharma's net income was $-812.68M. See Vor Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -3.49M$ -8.96M$ 0.00$ 0.00
Operating Expenses
$ 121.19M$ 122.54M$ 84.46M$ 69.02M$ 43.37M
Depreciation and Amortization
$ 3.53M$ 3.49M$ 8.96M$ 1.43M$ 605.00K
EBITDA
$ -117.66M$ -114.37M$ -83.13M$ -67.58M$ -42.76M
Operating Income
$ -121.19M$ -126.04M$ -93.42M$ -69.02M$ -43.37M
Other Income/Expenses
$ 4.27M$ 8.17M$ 1.32M$ 119.00K$ 29.00K
Pretax Income
$ -116.91M$ -117.86M$ -92.09M$ -68.90M$ -43.34M
Net Income
$ -116.91M$ -117.86M$ -92.09M$ -68.90M$ -43.34M
Per Share Metrics
Basic EPS
$ -34.00$ -35.00$ -46.60$ -37.80$ -26.60
Diluted EPS
$ -34.00$ -35.00$ -46.60$ -37.80$ -26.60
Weighted Average Shares Outstanding
3.44M 3.36M 1.98M 1.86M 1.86M
Weighted Average Shares Outstanding (Diluted)
3.44M 3.36M 1.98M 1.86M 1.86M
Currency in USD

Vor Biopharma Earnings and Revenue History